Bliss GVS is a fast-growing pharmaceutical company with a proven record of developing, manufacturing and marketing high-quality pharmaceutical formulations at affordable prices for the global market. Bliss GVS are amongst the world leaders in suppositories and pessaries dosage forms  with one of the largest portfolios and production capacities in this segment. Bliss GVS’ anti-malarial range also enjoys leadership positions in most African countries

 
Bliss GVS Pharma Ltd., incorporated in the year 1984, is a Mid Cap company (having a market cap of Rs 1639 Cr.) operating in Pharmaceuticals and health care sector. Bliss GVS primarily develops, manufactures and markets products across various therapeutic categories including Anti-fungal,  Laxative, Anti-haemorrhoidal, Anti-spasmodic, Anti-malarial, Anti-biotic, Anti-microbial, Anti-inflammatory, Antipyretic, Analgesic and several others
 
Bliss GVS Pharma manufactures female contraceptives, soft pessaries and suppositories. The company also manufactures to United States specification vaginal pessaries of Clotrimazole and Povidone Iodine in addition to anal suppositories for treatment of piles.
 
Bliss GVS has 5 manufacturing units and has presence in more than 60 countries. Two more manufacturing units are in the pipeline and expected to be functional shortly.
 
Among the African markets, Bliss GVS is touted as the segment leader for its range of Anti- Malarial products. 
 
In September 2011, Bliss GVS was awarded for its Outstanding Efforts in Research and Development by Government of India
 
For its performance in the exports sector, Bliss GVS received an award from the Indian Government in May 2014 for outstanding exports performance for the FY 2012-13
 
In December 2013, Bliss GVS was listed in Moneylife magazine’s ‘Wealth Creators 2004-2013′ list, an annual study of companies that have created the maximum wealth for investors over the past 10 years
 
In 2014 they have expanded their presence with the opening of a representative office in the Philippines. 
 

The Pharmaceuticals Export Promotion Council of India (Pharmexcil) presented Bliss GVS with an ‘Outstanding Exports Award’ (Silver) in the formulations category of firms with revenue between Rs. 300 – 1200 crores for the year 2012-13.

 
The company has a sophisticated  automatic plant situated at Palghar & they are aiming to become most modern and one of its kind in the indian Sub continent
 
In 2011 they have entered international market like Russia and common wealth of independent states markets
 
In 2012 they have started a manufacturing unit for Dry Powder for injection and  ENT drops at Daman.
 
 
Company has achieved a turnover of Rs 686 million in Q4 of 2014-15 as against Rs 554 million in the previous quarter.
 
Sales turnover and Net profit is steadily increasing from last 5 years.
 
Net profit has increased from Rs 406 million (2011) to Rs 600 million(2014-15)
 
EPS has increased  from 3.04(2011) to 5.82(2014-15) 
 
Book Value has increased from 12.91(2011) to 36.34(March -2014-15)
 
Considering the fact of proven potential, one can expect the steady growth for next few years and this stock can be considered as a safe investment for long term. 
 
At CMP 158 stock is a pretty good buy however, please buy in small chunks.